Try our Advanced Search for more refined results
March 24, 2022
Intrivo Diagnostics, Inc. v. Access Bio, Inc. et al
Case Number:
2:22-cv-01960
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 15, 2022
Access Bio, Others Hit Back At $1B 'Windfall' Virus Test Suit
Access Bio Inc. and two other medical companies hit back at Intrivo Diagnostics Inc.'s latest lawsuit accusing them of reneging on a deal to make COVID-19 tests, saying on Thursday that Intrivo is seeking a "windfall judgment" of $1 billion without the facts to back up its claims.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login